Alkermes, Inc. (ALKS) Reports In-Line Q4 Loss of 14c; Guides FY12
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $48.39 -1.57%
Financial Fact:
Product sales, net: 5.3M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Product sales, net: 5.3M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Alkermes, Inc. (NASDAQ: ALKS) reported Q4 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $42.28 million versus the consensus estimate of $46.32 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
- Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance
- Everpure (P) Tops Q2 EPS by 12c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
